Skip to content

Evaluate the Incidence of Sacral and Heel Pressure Ulcers During Acute Care After SCI

A Randomized Controlled Trial of the Effectiveness of a Five-layer Foam Dressing and the Heelmedix Boot for the Acute Prevention of Sacral and Heel Pressure Ulcers After Spinal Cord Injury

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04165395
Enrollment
165
Registered
2019-11-18
Start date
2019-08-19
Completion date
2021-01-31
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Keywords

Pressure Ulcers, Pressure Injury, Spinal Cord Injury, Prophylactic, Dressing

Brief summary

This study evaluates the effect of the application of a five-layer foam dressing on the sacrum as well as a boot applied on the heels as preventive measures in the development of pressure ulcers in patients hospitalized with spinal cord injury. In order to study their effectiveness in preventing wounds, we will compare the number of wounds that developed on the sacrum and heels in participants with and without preventive treatments. The study will also assess the severity of pressure ulcers in participants with and without preventive treatment if they do develop. Half of the participants will receive the usual standard care for the prevention of pressure ulcers without dressing and boot, while the other half, in additon to standard of care, will also have a preventive dressing on the sacrum as well as Heelmedix boot applied alternately on each foot.

Detailed description

Among all patient populations, individuals with spinaI cord injury are most vulnerable to pressure ulcers due to prolonged and severe immobilization, moisture exposure related to sphincters incontinence, friction and shear forces associated with difficult transfers, as well as abnormal micro vascular blood flow secondary to a disrupted autonomic function below the level of injury. These factors contribute to ischemia of the skin and underlying tissues over bony prominences, which lead to increased risk of pressure ulcers. Most severe spinal cord injuries are associated with higher risk of developing pressure ulcers and presenting more severe pressure ulcers. The sacral area and heels are most at risk for pressure ulcers in the spinal cord injury population. Consequently, prevention of pressure ulcers during the acute care hospitalization is of utmost importance. Patients will be randomized to the intervention group (prophylactic placement of foam dressing over sacrum and placement of a Heelmedix boot) or the control group (no prophylactic foam dressing over sacrum and no Heelmedix boot). Both groups will receive the standard-of-care at the facility for the prevention of pressure ulcers. The standard care can include a regular evaluation of the skin, a nutritional evaluation, the management of incontinence, the use of a gel mattress, the use of a low air loss pressure-reliving mattress, the use of safe patient mobilization, weekly assessment by a physiatrist, a change of position every 2 hours, as well as occupational therapy and physical therapy.

Interventions

DEVICEHeelmedix boot

Heelmedix boot will be installed alternately from one foot to the other.

DEVICEFive-layer foam dressing

Five-layer foam dressing applied on the sacrum within 48 hours of spinal surgery

Sponsors

Medline Industries
CollaboratorINDUSTRY
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Computer generated set of random numbers to determine group allocation with a ratio of 1:1

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male of female age 18 years of older; * Admitted to Hôpital du Sacré-Coeur de Montréal for a traumatic or non-traumatic spinal cord injury; * Spinal cord injury is either: Motor-complete (AIS A-B) or motor-incomplete (AIS C); * Neurological level of injury is between C0 and L2; * Patient or interpreter is able to understand English or French and provide informed consent.

Exclusion criteria

* AIS D Incomplete spinal cord injury; * Cauda equina syndrome or neurological level of injury below L2; * Sacral or heel pressure ulcer present at admission; * Presence of dermatological disease or systemic disease that might interfere with the outcome assessment (active dermatitis, urticarial, etc.); * Skin allergy to any components or ingredients of the foam dressing; * Any medical condition that would endanger a patient treated with the foam dressing; * Patient who are pregnant or nursing.

Design outcomes

Primary

MeasureTime frameDescription
Compare the incidence of pressure ulcers at the sacrum during the acute care hospitalization after a SCI between patients treated with prophylactic five-layer foam dressing at the sacrum area and vs. controlsDuring the acute care hospitalization, approx 6 weeksIncidence of new PU at the sacrum during the acute care hospitilization
Compare the incidence of PU at the heel during the acute care hospitalization after a SCI between patients with placement of a prophylactic Heelmedix boot and controlsDuring the acute care hospitalization, approx 6 weeksIncidence of new PU at the heel area during the acute care hospitilization

Secondary

MeasureTime frameDescription
Compare the severity of PU at the sacrum during the acute care hospitalization after a SCI between patients treated with prophylactic five-layer foam dressing at the sacrum area and controlsDuring the acute care hospitalization, approx 6 weeksGrade of PU based on the NPUAP grading system
Compare the severity of PU at the heel during the acute care hospitalization after a SCI between patients with placement of a prophylactic Heelmedix boot and controlsDuring the acute care hospitalization, approx 6 weeksGrade of PU based on the NPUAP grading system

Countries

Canada

Contacts

Primary ContactGeneviève Leblanc
genevieve.leblanc.ar.cnmtl@ssss.gouv.qc.ca1-514-338-2222
Backup ContactLouisane Dupré
louisane.dupre.cnmtl@ssss.gouv.qc.ca1-514-338-2222

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026